Caffeine citrate clinical trials
Also written Cafcit.
A product of Caffeine; its studies count on that page too.
How each study uses caffeine citrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the caffeine citrate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 Sept 1999 · CAFCIT · NDA 020793 (FDA, Drugs@FDA)
- European Union
- 19 Aug 2020 · Gencebok · EMEA/H/C/005435 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
34 studies that test it; most in 2026 (5)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 32
University of Michigan (2) · Ain Shams University (2) · McMaster University (2) · University of Melbourne (2) · University of North Carolina, Chapel Hill (1) · Al-Azhar University (1) · Children's Hospital of Chongqing Medical University (1) · University of Florence (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Caffeine
- One of Stimulants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test caffeine citrate, phase 3 first.
- Oct 2027Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory DistressPhase 2/3 · Ministry of Health, Saudi Arabia
- May 2027Caffeine Citrate in Preterm Infants at Risk of Apnea in ZambiaPhase 4 · University of Alabama at Birmingham
- Jun 2027Pharmacokinetics and Placental Transfer of CaffeinePhase 1 · Indiana University
- Aug 2027CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)Phase 2 · University of Alberta
Studies
Open first, then newest update. How each study uses caffeine citrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 34
- Improving Preterm Kidney Outcomes With CaffeineRecruitingPhase 2University of Wisconsin, MadisonNCT07262060Written as Caffeine citrate
- CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)Not yet recruitingPhase 2University of AlbertaNCT06972108Written as Caffeine citrate
- Caffeine Optimization for Oxygen Saturation Index in ELBW InfantsRecruitingPhase 2University of RochesterNCT07216365Written as Caffeine Citrate
- Caffeine Citrate in Preterm Infants at Risk of Apnea in ZambiaRecruitingPhase 4University of Alabama at BirminghamNCT06518603Written as Caffeine citrate 20mg/kg/day
- Pharmacokinetics and Placental Transfer of CaffeineRecruitingPhase 1Indiana UniversityNCT07570121Written as Caffeine citrate
- Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric PopulationRecruitingPhase 1/2University of ChicagoNCT06538584Written as Caffeine citrate 15mg/kg
- Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory DistressRecruitingPhase 2/3Ministry of Health, Saudi ArabiaNCT06026163Written as Caffeine citrate
- PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]Not yet recruitingNot applicableUniversity of MelbourneNCT06461429Written as Caffeine citrate 20 mg/kg load and 10 mg/kg daily maintenance.
- Caffeine Citrate to Improve Neonatal Outcomes.Not yet recruitingNot applicableUniversity of MelbourneNCT06972849Written as Caffeine citrate
- The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrateRecruitingPhase 4Semmelweis UniversityNCT06401083Written as Caffeine citrate
- The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) StudyCompletedPhase 2University of MichiganNCT05574400Written as Caffeine citrate
- Dose Optimization of Caffeine for HIEActive, not recruitingPhase 1University of North Carolina, Chapel HillNCT06448780Written as Caffeine citrate 20 mg/kg
- Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) TrialTerminatedPhase 3NICHD Neonatal Research NetworkNCT03340727Written as Caffeine Citrate
- CaffeinICU Study - A Study on Oral Caffeine in ICU Patients With ComaSuspendedPhase 2Singapore General HospitalNCT05232734Written as Caffeine Citrate 20 MG/ML Oral Solution
- PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic HypothermiaWithdrawnPhase 1University of ArkansasNCT05295784Written as Caffeine citrate
- the Incidence of Necrotizing Enterocolitis in Preterm With Respiratory Distress Syndrome Undergoing Caffeine TherapyActive, not recruitingEarly Phase 1Al-Azhar UniversityNCT06097767Written as Caffeine citrate
- Target Weaning Oxygen to Determine Cafffeine Duration for AOPCompletedPhase 4Children's Hospital of Chongqing Medical UniversityNCT04868565Written as Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]
- Caffeine Treatment in in the Delivery RoomCompletedNot applicableUniversity of FlorenceNCT04044976Written as Caffeine Citrate
- Caffeine and Neurologic Recovery Following Surgery and General AnesthesiaCompletedEarly Phase 1University of MichiganNCT03577730Written as Caffeine Citrate
- Early Caffeine in Preterm NeonatesStatus unknownPhase 4Jennifer ShepherdNCT03086473Written as Caffeine Citrate
See all 34 studies that test caffeine citrate →
Given beside what is tested · 1 — caffeine citrate is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with caffeine citrate
- Caffeine for Hypoxic-Ischemic EncephalopathyCompletedPhase 1University of North Carolina, Chapel HillNCT03913221Written as Caffeine Citrate 5 mg/kg
- Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)CompletedPhase 2State University of New York - Downstate Medical CenterNCT02344225Written as Caffeine citrate
Codes
What other systems call caffeine citrate · ClinicalTrials.gg INT002829
- MeSH (NLM) C026189caffeine citrateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U26EO4675QCAFFEINE CITRATEConfirmed FDA, NLM, Wikidata
- RxNorm 20033Confirmed FDA, Wikidata
- Wikidata Q2974480caffeine citrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1033Caffeine CitrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C026189 | caffeine citrate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U26EO4675Q | CAFFEINE CITRATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 20033 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2974480 | caffeine citrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1033 | Caffeine Citrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.